Citius Transnet InvIT will open its IPO for subscription on April 17, 2026, and close the issue on April 21, 2026. The company is launching the issue through the book-building route.
Through this public offering, the company aims to raise nearly ₹1,105 crore. The entire amount will come from a fresh issue worth ₹1,105 crore, while details of the offer-for-sale portion are yet to be announced.
The company has fixed the IPO price band at ₹99 to ₹100 per unit. Under the allocation structure, it has reserved 75% of the issue for Qualified Institutional Buyers (QIBs) and 25% for High Net-worth Individuals (HNIs). The company has not yet disclosed the retail investor quota.
Citius Transnet InvIT is likely to list on both the BSE and NSE on April 24, 2026. The registrar will probably finalize the basis of allotment on April 22, 2026.
Citius Transnet InvIT IPO Details
| IPO Open Date | April 17, 2026 |
| IPO Close Date | April 21, 2026 |
| Face Value | ₹[.] Per Equity Share |
| IPO Price Band | ₹99 to ₹100 Per Share |
| Issue Size | Approx ₹1,105 Crores |
| Fresh Issue | Approx ₹1,105 Crores |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
IPO Reservation
| Investor Category | Shares (%) |
| QIB (Ex. Anchor) | 75% |
| NII Shares Offered | 25% |
Citius Transnet InvIT IPO Timeline
- IPO Opening Date: April 17, 2026
- IPO Closing Date: April 21, 2026
- Allotment Date: April 22, 2026
- Listing Date: April 24, 2026
Citius Transnet InvIT IPO Dates
The Citius Transnet InvIT IPO date is April 17 and the close date is April 21. The Citius Transnet InvIT IPO allotment will be finalized on April 22 and the IPO listing on April 24.
| IPO Open Date: | April 17, 2026 |
| IPO Close Date: | April 21, 2026 |
| Basis of Allotment: | April 22, 2026 |
| Refunds: | April 23, 2026 |
| Credit to Demat Account: | April 23, 2026 |
| IPO Listing Date: | April 24, 2026 |
| IPO Bidding Cut-off Time: | April 21, 2026 – 5 PM |
Citius Transnet InvIT IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 16 April | ₹- | – | -% |
| 15 April | ₹- | – | -% |
| 14 April | ₹- | – | -% |
| 13 April | ₹- | – | -% |
| 11 April | ₹- | – | -% |
| 10 April | ₹- | – | -% |
Financial Performance
Citius Transnet InvIT reported revenue of ₹2,165.62 crore for FY2025, compared to ₹2,038.53 crore in FY2024, showing steady year-on-year growth.
The company also narrowed its losses during the same period. Net loss stood at ₹417.75 crore in FY2025, significantly lower than the loss of ₹774.12 crore reported in FY2024.
Based on the company’s financial performance and business outlook, the IPO may be more suitable for investors with a long-term investment horizon.
About Citius Transnet Investment Trust
Citius Transnet Investment Trust operates as an infrastructure investment trust focused on India’s transportation sector. The trust owns and manages transport-related infrastructure assets, primarily roads and highways.
Its current portfolio includes 10 road assets, consisting of 7 toll-based projects and 3 annuity-based projects. Together, these assets span more than 3,400 lane kilometres across the country.
The trust is managed by EAAA TransInfra Managers Limited (ETML), a part of the EAAA Alternatives platform. EAAA Alternatives is among the country’s major alternative asset managers, with assets under management exceeding ₹6,29,000 crore.
During FY2025, Citius Transnet generated gross revenue of approximately ₹2,050 crore from toll collections and annuity receipts. The trust also has a strong right-of-first-offer (ROFO) pipeline that includes 11 Hybrid Annuity Model (HAM) projects covering around 2,380 lane kilometres.
Citius Transnet InvIT IPO GMP Today
As of now, the Grey Market Premium (GMP) for the Citius Transnet InvIT IPO has not been reported.
- Current GMP: Not Available
- Estimated Listing Gain: Not Available
GMP Disclaimer
- Grey Market Premium figures are unofficial and may change frequently before the stock is listed. Investors should avoid making investment decisions solely on the basis of GMP.
- A strong GMP does not always guarantee good listing performance, while a weak GMP does not necessarily indicate poor long-term prospects.
- Kostak Rate refers to the premium received when an investor sells an IPO application in the unofficial market before allotment or listing.
- Before applying, investors should focus on the company’s financial position, business quality, future growth prospects, and valuation rather than relying only on grey market trends.